Does NEORAL Cause Interstitial lung disease? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Interstitial lung disease have been filed in association with NEORAL. This represents 4.3% of all adverse event reports for NEORAL.
11
Reports of Interstitial lung disease with NEORAL
4.3%
of all NEORAL reports
6
Deaths
3
Hospitalizations
How Dangerous Is Interstitial lung disease From NEORAL?
Of the 11 reports, 6 (54.5%) resulted in death, 3 (27.3%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEORAL. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does NEORAL Cause?
Blood creatinine increased (18)
Death (17)
Immunosuppressant drug level increased (14)
Renal failure (13)
Kidney transplant rejection (11)
Renal impairment (11)
Maternal exposure during pregnancy (10)
Oral administration complication (9)
Pyrexia (9)
Renal failure acute (9)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which NEORAL Alternatives Have Lower Interstitial lung disease Risk?
NEORAL vs NEOSTIGMINE
NEORAL vs NEOSTIGMINE METHYLSULFATE
NEORAL vs NEPAFENAC
NEORAL vs NERATINIB
NEORAL vs NETARSUDIL